These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 7531286
1. Intensification and depletion of specific bulky renal DNA adducts (I-compounds) following exposure of male F344 rats to the renal carcinogen ferric nitrilotriacetate (Fe-NTA). Randerath E, Watson WP, Zhou GD, Chang J, Randerath K. Mutat Res; 1995 Feb; 341(4):265-79. PubMed ID: 7531286 [Abstract] [Full Text] [Related]
2. Ferric nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress. Athar M, Iqbal M. Carcinogenesis; 1998 Jun; 19(6):1133-9. PubMed ID: 9667754 [Abstract] [Full Text] [Related]
3. Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Toyokuni S, Luo XP, Tanaka T, Uchida K, Hiai H, Lehotay DC. Free Radic Biol Med; 1997 Jun; 22(6):1019-27. PubMed ID: 9034241 [Abstract] [Full Text] [Related]
6. Age-dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parenteral administration of ferric nitrilotriacetate commensurate with its differential toxicity: implications for the involvement of HNE-protein adducts in oxidative stress and carcinogenesis. Iqbal M, Giri U, Giri DK, Alam MS, Athar M. Arch Biochem Biophys; 1999 May 01; 365(1):101-12. PubMed ID: 10222044 [Abstract] [Full Text] [Related]
8. Inhibitory effects of melatonin on ferric nitrilotriacetate-induced lipid peroxidation and oxidative DNA damage in the rat kidney. Qi W, Reiter RJ, Tan DX, Manchester LC, Kim SJ, Garcia JJ. Toxicology; 1999 Nov 29; 139(1-2):81-91. PubMed ID: 10614689 [Abstract] [Full Text] [Related]
9. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Nishiyama Y, Suwa H, Okamoto K, Fukumoto M, Hiai H, Toyokuni S. Jpn J Cancer Res; 1995 Dec 29; 86(12):1150-8. PubMed ID: 8636003 [Abstract] [Full Text] [Related]
10. Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate. Okazaki Y, Iqbal M, Okada S. Biochim Biophys Acta; 2005 Jun 10; 1740(3):357-66. PubMed ID: 15949703 [Abstract] [Full Text] [Related]
11. Evidence that ferric nitrilotriacetate mediates oxidative stress by down-regulating DT-diaphorase activity: implications for carcinogenesis. Iqbal M, Sharma SD, Rahman A, Trikha P, Athar M. Cancer Lett; 1999 Jul 01; 141(1-2):151-7. PubMed ID: 10454256 [Abstract] [Full Text] [Related]
12. In vitro transformation of rat renal cells by treatment with ferric nitrilotriacetate. Kakehashi C, Mori M, Kawabata T, Okada S. Acta Med Okayama; 2001 Apr 01; 55(2):97-103. PubMed ID: 11332205 [Abstract] [Full Text] [Related]
14. Vitamin E inhibits hepatic oxidative stress, toxicity and hyperproliferation in rats treated with the renal carcinogen ferric nitrilotriacetate. Agarwal MK, Iqbal M, Athar M. Redox Rep; 2005 Apr 01; 10(2):62-70. PubMed ID: 15949125 [Abstract] [Full Text] [Related]
15. Sex hormone-dependent renal cell carcinogenesis induced by ferric nitrilotriacetate in Wistar rats. Deguchi J, Miyamoto M, Okada S. Jpn J Cancer Res; 1995 Nov 01; 86(11):1068-71. PubMed ID: 8567398 [Abstract] [Full Text] [Related]
19. Attenuation of iron-nitrilotriacetate (Fe-NTA)-mediated renal oxidative stress, toxicity and hyperproliferative response by the prophylactic treatment of rats with garlic oil. Iqbal M, Athar M. Food Chem Toxicol; 1998 Jun 01; 36(6):485-95. PubMed ID: 9674956 [Abstract] [Full Text] [Related]
20. Differential role of hydrogen peroxide and organic hydroperoxides in augmenting ferric nitrilotriacetate (Fe-NTA)-mediated DNA damage: implications for carcinogenesis. Iqbal M, Sharma SD, Mizote A, Fujisawa M, Okada S. Teratog Carcinog Mutagen; 2003 Jun 01; Suppl 1():13-21. PubMed ID: 12616593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]